Vyne Therapeutics Announces Reverse Stock Split: A Game-Changing Move for Investors
VYNE Therapeutics Announces Reverse Stock Split Common stock expected to begin trading on split-adjusted basis on February 13, 2023 BRIDGEWATER, N.J., Feb. 10, 2023 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced that its…